NCT05265052 2026-03-11
3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
3D Medicines
Phase 2 Not yet recruiting
3D Medicines
Bilecik Seyh Edebali Universitesi
Taian Cancer Hospital
National and Kapodistrian University of Athens
Mersin University
Hanoi Medical University
National Cancer Institute, Egypt
National Institutes of Health Clinical Center (CC)
The Fourth Affiliated Hospital of Zhejiang University School of Medicine